Literature DB >> 32560971

Animal models of psoriasis-highlights and drawbacks.

Michael P Schön1, Veit Manzke2, Luise Erpenbeck2.   

Abstract

Research into the pathophysiology of psoriasis remains challenging, because this disease does not occur naturally in laboratory animals. However, specific aspects of its complex immune-pathology can be illuminated through transgenic, knockout, xenotransplantation, immunological reconstitution, drug-induced, or spontaneous mutation models in rodents. Although some of these approaches have already been pursued for more than 5 decades and even more models have been described in recent times, they have surprisingly not yet been systematically validated. As a consequence, researchers regularly examine specific aspects that only partially reflect the complex overall picture of the human disease. Nonetheless, animal models are of great utility to investigate inflammatory mediators, the communication between cells of the innate and the adaptive immune systems, the role of resident cells as well as new therapies. Of note, various manipulations in experimental animals resulted in rather similar phenotypes. These were called "psoriasiform", "psoriasis-like" or even "psoriasis" usually on the basis of some similarities with the human disorder. Xenotransplantation of human skin onto immunocompromised animals can overcome this limitation only in part. In this review, we elucidate approaches for the generation of animal models of psoriasis and assess their strengths and limitations with a certain focus on more recently developed models.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Psoriasis; adoptive transfer; animal model; chronic inflammation; dermatology; drug testing; epidermis; hyperproliferation; imiquimod; preclinical; preclinical therapeutic study; skin immunity; skin inflammation; transgenic; xenotransplantation

Year:  2020        PMID: 32560971     DOI: 10.1016/j.jaci.2020.04.034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Cutaneous nerve fibers participate in the progression of psoriasis by linking epidermal keratinocytes and immunocytes.

Authors:  Si-Qi Chen; Xue-Yan Chen; Ying-Zhe Cui; Bing-Xi Yan; Yuan Zhou; Zhao-Yuan Wang; Fan Xu; Yan-Zhou Huang; Yu-Xin Zheng; Xiao-Yong Man
Journal:  Cell Mol Life Sci       Date:  2022-04-30       Impact factor: 9.261

2.  TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy.

Authors:  Rinkesh K Gupta; Donald T Gracias; Daniela Salgado Figueroa; Haruka Miki; Jacqueline Miller; Kai Fung; Ferhat Ay; Linda Burkly; Michael Croft
Journal:  Sci Immunol       Date:  2021-11-19

3.  Cytokine induced 3-D organotypic psoriasis skin model demonstrates distinct roles for NF-κB and JAK pathways in disease pathophysiology.

Authors:  Viktor Todorović; Heath A McDonald; Paul Hoover; Joseph B Wetter; Anastasia E Marinopoulos; Clarissa L Woody; Loan Miller; Ariel Finkielsztein; Robert W Dunstan; Amy S Paller; Prisca Honore; Spiro Getsios; Victoria E Scott
Journal:  Exp Dermatol       Date:  2022-03-07       Impact factor: 4.511

Review 4.  Peripheral Mechanisms of Itch.

Authors:  Changxiong J Guo; Nathaniel S Grabinski; Qin Liu
Journal:  J Invest Dermatol       Date:  2021-11-24       Impact factor: 7.590

5.  Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis.

Authors:  Diana Ana-Maria Nițescu; Horia Păunescu; Alina Elena Ștefan; Laurențiu Coman; Corneliu Cristian Georgescu; Andrei Constantin Stoian; Daniela Gologan; Ion Fulga; Oana Andreia Coman
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

Review 6.  New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

Authors:  Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-07-22       Impact factor: 8.551

7.  Drug Delivery through the Psoriatic Epidermal Barrier-A "Skin-On-A-Chip" Permeability Study and Ex Vivo Optical Imaging.

Authors:  Dorottya Kocsis; Szabina Horváth; Ágnes Kemény; Zsófia Varga-Medveczky; Csaba Pongor; Rózsa Molnár; Anna Mihály; Dániel Farkas; Bese Márton Naszlady; András Fülöp; András Horváth; Balázs Rózsa; Erika Pintér; Rolland Gyulai; Franciska Erdő
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

8.  Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases.

Authors:  Shintaro Akiyama; Atsushi Sakuraba
Journal:  J Transl Autoimmun       Date:  2021-05-25

9.  Effects of Dietary Protein Intake on Cutaneous and Systemic Inflammation in Mice with Acute Experimental Psoriasis.

Authors:  Tanja Knopp; Tabea Bieler; Rebecca Jung; Julia Ringen; Michael Molitor; Annika Jurda; Thomas Münzel; Ari Waisman; Philip Wenzel; Susanne Helena Karbach; Johannes Wild
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

10.  Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model.

Authors:  Nuria Gago-López; Carmen Lagunas Arnal; Juan J Perez; Erwin F Wagner
Journal:  Exp Dermatol       Date:  2021-05-28       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.